Drug Research

Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) in tumours can be targeted to prevent and treat cancer. Together with collaborators from the United States and National Cancer Centre Singapore...

Regeneron Pharmaceuticals, Inc. and Sanofi have restructured their global Immuno-oncology Discovery and Development Agreement for new immuno-oncology cancer treatments. The 2015 Agreement was scheduled to end in approximately mid-2020, and this revision provides for ongoing collaborative...

LabCorp, a leading global life sciences company, and GENFIT , a biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting liver diseases, have announced the signing of a licensing agreement between GENFIT and Covance, LabCorp’s...

Propanc Biopharma, Inc , a clinical stage biopharmaceutical company focused on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, announced that a cooperation agreement has been entered...

Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment of Multiple Sclerosis, and gene therapy for the treatment of neuropathic pain, has licensed an...

Innovation and collaboration are the lifeblood of the life sciences. Without them, both research and business come to a standstill. Knowing this, how do pharmaceutical and biotechnology companies get the blood pumping, communicate their position to the marketplace as well...

Imagine the Possibilities: What if innovations in the life sciences supply chain kept up with innovations in medicines and treatments? With many serialization and track & trace regulations in the compliance period, and others (e.g., EU FMD, US DSCSA) on...